Partner Fund Management »

Treace Med Concepts shares owned by Partner Fund Management

Quarter-by-quarter ownership of Treace Med Concepts (TMCI) shares owned by Partner Fund Management from 13F filings

Historical chart of Partner Fund Management investment in Treace Med Concepts

Tip: Access up to 7 years of quarterly data

All positions including Treace Med Concepts held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Treace Med Concepts by Partner Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $123k 50k 2.45

More positions owned by Partner Fund Management

Tenet Healthcare Corp Com New (THC)
Eli Lilly & Co. (LLY)
Axsome Therapeutics (AXSM)
Centene Corporation (CNC)
Penumbra (PEN)
Ascendis Pharma A/s Sponsored Adr (ASND)
United Therapeutics Corporation (UTHR)
Bridgebio Pharma (BBIO)
Adma Biologics (ADMA)
Neurocrine Biosciences (NBIX)
Glaukos (GKOS)
Thermo Fisher Scientific (TMO)
Edwards Lifesciences (EW)
Icon SHS (ICLR)
Inhibrx Biosciences (INBX)

View all positions for Partner Fund Management

Top funds holding Treace Med Concepts

Gagnon Securities
BlackRock
Vanguard Group
Millennium Management
Atlantic Trust
First Eagle Investment Management
Vanguard Capital Management
Geode Capital Management
State Street Corporation
Acadian Asset Management
D. E. Shaw & Co
Weber Capital Management
UBS Group
Vanguard Portfolio Management
GSA Capital Partners

View all funds holding Treace Med Concepts